G1 Therapeutics, Inc. (GTHX)
NASDAQ: GTHX · IEX Real-Time Price · USD
3.630
-0.010 (-0.27%)
At close: Jul 19, 2024, 4:00 PM
3.580
-0.050 (-1.38%)
Pre-market: Jul 22, 2024, 7:31 AM EDT
G1 Therapeutics Market Cap
G1 Therapeutics has a market cap or net worth of $189.78 million as of July 22, 2024. Its market cap has increased by 50.50% in one year.
Market Cap
189.78M
Enterprise Value
171.43M
1-Year Change
50.50%
Ranking
Category
Stock Price
$3.63
Market Cap Chart
Since May 17, 2017, G1 Therapeutics's market cap has decreased from $400.00M to $189.78M, a decrease of -52.55%. That is a compound annual growth rate of -9.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 189.80M | 20.05% |
| Dec 29, 2023 | 158.10M | -32.15% |
| Dec 30, 2022 | 233.00M | -46.34% |
| Dec 31, 2021 | 434.20M | -36.56% |
| Dec 31, 2020 | 684.40M | -31.10% |
| Dec 31, 2019 | 993.30M | 39.49% |
| Dec 31, 2018 | 712.10M | 26.62% |
| Dec 29, 2017 | 562.40M | 40.60% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| P3 Health Partners | 193.35M |
| Pyxis Oncology | 192.86M |
| Candel Therapeutics | 192.22M |
| Trevi Therapeutics | 190.88M |
| 908 Devices | 188.98M |
| Inhibrx | 187.03M |
| Outlook Therapeutics | 187.01M |
| EDAP TMS | 186.82M |